CNS Pharmaceuticals Q3 EPS $(0.25) Misses $(0.12) Estimate
CNS Pharmaceuticals Q3 EPS $(0.25) Misses $(0.12) Estimate
cns pharmaceuticals 第三季度每股收益 $(0.25) 未達到 $(0.12) 的預期
CNS Pharmaceuticals (NASDAQ:CNSP) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.12) by 108.33 percent. This is a 99.54 percent increase over losses of $(54.14) per share from the same period last year.
cns pharmaceuticals(納斯達克:CNSP)報告每股虧損0.25美元,低於分析師共識預期的0.12美元,下降108.33%。這是與去年同期每股虧損54.14美元相比增長了99.54%。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。